197 related articles for article (PubMed ID: 25163552)
1. Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.
Luo XJ; Liu B; Ma QL; Peng J
Curr Drug Targets; 2014; 15(10):948-55. PubMed ID: 25163552
[TBL] [Abstract][Full Text] [Related]
2. Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes.
Fu SH; Zhang HF; Yang ZB; Li TB; Liu B; Lou Z; Ma QL; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):87-94. PubMed ID: 24081521
[TBL] [Abstract][Full Text] [Related]
3. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
4. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity.
Wei SJ; Xing JH; Wang BL; Xue L; Wang JL; Li R; Qin WD; Wang J; Wang XP; Zhang MX; Chen YG
Biochim Biophys Acta; 2013 Mar; 1833(3):479-86. PubMed ID: 23159776
[TBL] [Abstract][Full Text] [Related]
6. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart.
Endo J; Sano M; Katayama T; Hishiki T; Shinmura K; Morizane S; Matsuhashi T; Katsumata Y; Zhang Y; Ito H; Nagahata Y; Marchitti S; Nishimaki K; Wolf AM; Nakanishi H; Hattori F; Vasiliou V; Adachi T; Ohsawa I; Taguchi R; Hirabayashi Y; Ohta S; Suematsu M; Ogawa S; Fukuda K
Circ Res; 2009 Nov; 105(11):1118-27. PubMed ID: 19815821
[TBL] [Abstract][Full Text] [Related]
7. Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Panisello-Roselló A; Lopez A; Folch-Puy E; Carbonell T; Rolo A; Palmeira C; Adam R; Net M; Roselló-Catafau J
World J Gastroenterol; 2018 Jul; 24(27):2984-2994. PubMed ID: 30038465
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury.
Gong D; Zhang Y; Zhang H; Gu H; Jiang Q; Hu S
Cardiovasc Toxicol; 2012 Dec; 12(4):350-8. PubMed ID: 22814936
[TBL] [Abstract][Full Text] [Related]
9. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1.
Gomes KM; Bechara LR; Lima VM; Ribeiro MA; Campos JC; Dourado PM; Kowaltowski AJ; Mochly-Rosen D; Ferreira JC
Int J Cardiol; 2015 Jan; 179():129-38. PubMed ID: 25464432
[TBL] [Abstract][Full Text] [Related]
10. Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells.
Ding J; Zhang Q; Luo Q; Ying Y; Liu Y; Li Y; Wei W; Yan F; Zhang H
Crit Care Med; 2016 Jul; 44(7):e544-52. PubMed ID: 26757166
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological enrollment of aldehyde dehydrogenase modulators to assist treating ischemia reperfusion-induced intestinal injury: is there a gap to be bridged?
Dollé L
Clin Sci (Lond); 2017 Jun; 131(11):1137-1140. PubMed ID: 28533269
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde.
Ma H; Guo R; Yu L; Zhang Y; Ren J
Eur Heart J; 2011 Apr; 32(8):1025-38. PubMed ID: 20705694
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside.
Pang JJ; Barton LA; Chen YG; Ren J
Sheng Li Xue Bao; 2015 Dec; 67(6):535-44. PubMed ID: 26701629
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.
Contractor H; Støttrup NB; Cunnington C; Manlhiot C; Diesch J; Ormerod JO; Jensen R; Bøtker HE; Redington A; Schmidt MR; Ashrafian H; Kharbanda RK
Basic Res Cardiol; 2013 May; 108(3):343. PubMed ID: 23525499
[TBL] [Abstract][Full Text] [Related]
15. Piperlonguminine a new mitochondrial aldehyde dehydrogenase activator protects the heart from ischemia/reperfusion injury.
Yoval-Sánchez B; Calleja LF; de la Luz Hernández-Esquivel M; Rodríguez-Zavala JS
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129684. PubMed ID: 32679250
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia.
Sun X; Zhu H; Dong Z; Liu X; Ma X; Han S; Lu F; Wang P; Qian S; Wang C; Shen C; Zhao X; Zou Y; Ge J; Sun A
Redox Biol; 2017 Oct; 13():196-206. PubMed ID: 28582728
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?
Budas GR; Disatnik MH; Mochly-Rosen D
Trends Cardiovasc Med; 2009 Jul; 19(5):158-64. PubMed ID: 20005475
[TBL] [Abstract][Full Text] [Related]
18. Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance.
Gu C; Xing Y; Jiang L; Chen M; Xu M; Yin Y; Li C; Yang Z; Yu L; Ma H
PLoS One; 2013; 8(9):e74050. PubMed ID: 24040162
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Aldehyde Dehydrogenase in Myocardial Ischemic and Ischemia-Reperfusion Injury.
Ding J; Yang Z; Ma H; Zhang H
Adv Exp Med Biol; 2019; 1193():107-120. PubMed ID: 31368100
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury.
Liu B; Wang J; Li M; Yuan Q; Xue M; Xu F; Chen Y
Oncotarget; 2017 Mar; 8(12):19413-19426. PubMed ID: 28038474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
